EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma

Wan-Yuan Ruan, Lu Zhang, Shan Lei, Zhi-Rui Zeng iD, Yu-Shi Yang, Wen-Peng Cao, Qiu-Yao Hao, Min Lu, Xiao-Bin Tian, Pai-Lan Peng

Journal of Cellular and Molecular Medicine · 2023

DOI: 10.1111/jcmm.17780 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Cellular and Molecular Medicine, 2023. Verfasst von Wan-Yuan Ruan und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Ferroptosis, Liver Neoplasms. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Inflammation and ferroptosis crosstalk complexly with immune microenvironment of hepatocellular carcinoma (HCC), thus affecting the efficacy of immunotherapy. Herein, our aim was to identify the inflammation‐associated ferroptosis (IAF) biomarkers for contributing HCC. A total of 224 intersecting DEGs identified from different inflammation‐ and ferroptosis‐subtypes were set as IAF genes. Seven of them including ADH4 , APOA5 , CFHR3 , CXCL8 , FTCD , G6PD and PON1 were used for construction of a risk model which classified HCC patients into two groups (high and low risk). HCC patients in the high‐risk group exhibited shorter survival rate and higher immune score, and were predicted to have higher respond rate in immune checkpoint inhibition (ICI) therapy. Levels of the seven genes were significantly changed in HCC tissues in comparison to adjacent tissues. After inserting the gene expression into the risk model, we found that the risk model exhibited the higher diagnostic value for distinguish HCC tissues compared each single gene. Furthermore, HCC tissues from our research group with high‐risk score exhibited more cases of microsatellite instability (MSI), heavier tumour mutational burden (TMB), higher expression level of PDL1 and cells with CD8. Knockdown of APOA5 reduced HCC cell proliferation combining with elevating inflammation and ferroptosis levels. In conclusion, we considered APOA5 maybe a novel target for suppressing HCC via simultaneously elevating inflammation and ferroptosis levels, and signature constructed by seven IAF genes including ADH4 , APOA5 , CFHR3 , CXCL8 , FTCD , G6PD and PON1 can act as a biomarker for optimising the diagnosis, prognosis evaluation and immunotherapy options in HCC patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularFerroptosisLiver NeoplasmsHumansImmunotherapyInflammationTumor MicroenvironmentAryldialkylphosphatase

Stichwörter der Autor:innen

diagnosishepatocellular carcinomaimmunotherapy optimisationinflammation-associated ferroptosis geneprognosis evaluation

Substanzen

PON1 protein, humanAryldialkylphosphatase

Autor:innen und Institutionen

  • Department of Gastroenterology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • School of Clinical Medicine, Guizhou Medical University, Guiyang, China.
  • School of Basic Medicine, Guizhou Medical University, Guiyang, China.
  • Department of Pathology, The Affiliated Hospital of Guizhou Medical University, Guiyang, China.
  • Department of Gastroenterology, Zhujiang Hospital, Southern Medical University, Guangzhou, China.

ORCID-Profile: Zhi-Rui Zeng

Förderung

  • National Natural Science Foundation of China

Zitieren

APA

Ruan, W. Y., Zhang, L., Lei, S., Zeng, Z. R., Yang, Y. S., Cao, W. P., Hao, Q. Y., Lu, M., Tian, X. B., & Peng, P. L. (2023). An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. https://doi.org/10.1111/jcmm.17780

Vancouver

Ruan WY, Zhang L, Lei S, Zeng ZR, Yang YS, Cao WP, et al. An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma. Journal of Cellular and Molecular Medicine. 2023. doi:10.1111/jcmm.17780

BibTeX
@article{Ruan2023,
  author = {Ruan, Wan-Yuan and Zhang, Lu and Lei, Shan and Zeng, Zhi-Rui and Yang, Yu-Shi and Cao, Wen-Peng and Hao, Qiu-Yao and Lu, Min and Tian, Xiao-Bin and Peng, Pai-Lan},
  title = {An inflammation‐associated ferroptosis signature optimizes the diagnosis, prognosis evaluation and immunotherapy options in hepatocellular carcinoma},
  journal = {Journal of Cellular and Molecular Medicine},
  year = {2023},
  doi = {10.1111/jcmm.17780}
}
Kostenlos starten →